Biomedical Applications: Advances in Bioengineering and Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 2521
Special Issue Editors
Interests: intracellular nanoparticle trafficking; biological properties of natural and synthetic compounds; immunomodulation by biomaterials
Special Issue Information
Dear Colleagues,
In recent years, significant progress has been made developing bioengineering and intelligent drug delivery systems. In the area of bioengineering, there have been outstanding advances in biological therapy with proteins and antibodies, the development of new materials for tissue engineering, and the generation of biosensing systems. In parallel, as well as advances in bioengineering, drug delivery, and delivery systems have been successfully researched and developed with the idea of improving efficiency and, thus, reducing adverse drug effects.
These areas of development include various scientific aspects that must be addressed to understand the processes involved and the development of efficient systems. In this context, the study of physical and chemical interactions between the components of biological systems and the relationships between biochemical mechanisms and the physiological implications of the processes studied have significantly impacted the success of new proposals.
This Special Issue brings together new results of research related to the different aspects of bioengineering development, focusing on the investigation of therapeutic alternatives in addition to allowing the incorporation of reviews and short communications that offer readers a broad vision of the capabilities these developing technologies have.
Dr. María Carolina Otero
Dr. Yusser Olguín
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomedicine
- tissue engineering
- biomaterials
- drug carrier
- biological therapy
